Loading...
Pherecydes Pharma SA
ALPHE.PA•EURONEXT
Healthcare
Biotechnology
€2.00
€-0.01(-0.50%)
Pherecydes Pharma SA (ALPHE.PA) Company Profile & Overview
Explore Pherecydes Pharma SA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Pherecydes Pharma SA (ALPHE.PA) Company Profile & Overview
Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections. The company was founded in 2006 and is based in Romainville, France.
SectorHealthcare
IndustryBiotechnology
CEOThibaut du Fayet
Contact Information
Company Facts
29 Employees
IPO DateFeb 5, 2021
CountryFR